Loading next page...
/lp/wiley/genetic-variants-in-the-histone-methylation-and-acetylation-pathway-BY9WwnScMg
- Publisher
- Wiley Subscription Services, Inc., A Wiley Company
- Copyright
- © 2018 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd
- ISSN
- 1751-2972
- eISSN
- 1751-2980
- D.O.I.
- 10.1111/1751-2980.12574
- Publisher site
- See Article on Publisher Site
Abstract
INTRODUCTIONThe global cancer burden has continued to climb over the past decade. The development of cancer is thought to be a consequence of the accumulation of genetic alterations. Genome‐wide association studies evaluate genetic variants across the genome of different individuals to discern whether any one variant is related to a particular disease. The relation between single nucleotide polymorphisms (SNPs) and specific human diseases like cancer is a major focus of genome‐wide association studies. However, the analysis of the associations of a single site can explain only a small part of the genetic mechanism. Integrative analysis based on pathway levels can be used to investigate the cumulative relationship between a group of loci or genes and diseases.The epigenetic regulation of gene expression by histone modifications has recently been shown to be involved in cancer development. Histone methylation and acetylation are common histone modifications that play essential roles in the development of cancer. Reversible histone methylation and acetylation are important processes that are catalyzed by histone demethylases, histone methyltransferases, histone deacetylases and histone acetyltransferases. Aberrations in histone acetylation and methylation occur frequently in cancer, including changes in their distribution and levels in different genetic regions. Therefore, histone acetyltransferases, histone deacetylases, histone
Journal
Journal of Digestive Diseases – Wiley
Published: Jan 1, 2018
Keywords: ; ;
Recommended Articles
Loading...
References
-
Genetic alteration and gene expression modulation during cancer progressionGarnis, C; Buys, TP; Lam, WL
-
Chapter 11: genome‐wide association studiesBush, WS; Moore, JH
-
Histone methylation: a dynamic mark in health, disease and inheritanceGreer, EL; Shi, Y
-
Histone modifiers in cancer: friends or foes?Cohen, I; Poręba, E; Kamieniarz, K; Schneider, R
-
Epigenetic regulation of cancer growth by histone demethylasesLim, S; Metzger, E; Schüle, R; Kirfel, J; Buettner, R
-
Erasers of histone acetylation: the histone deacetylase enzymesSeto, E; Yoshida, M
-
Regulation of chromatin by histone modificationsBannister, AJ; Kouzarides, T
-
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinomaAbnet, CC; Freedman, ND; Hu, N
-
Genome‐wide association study of prostate cancer identifies a second risk locus at 8q24Yeager, M; Orr, N; Hayes, RB
-
Principal components analysis corrects for stratification in genome‐wide association studiesPrice, AL; Patterson, NJ; Plenge, RM; Weinblatt, ME; Shadick, NA; Reich, D
-
A multi‐stage genome‐wide association study of bladder cancer identifies multiple susceptibility lociRothman, N; Garcia‐Closas, M; Chatterjee, N
-
Genetic variants in the inositol phosphate metabolism pathway and risk of different types of cancerTan, J; Yu, CY; Wang, ZH
-
Pathway analysis by adaptive combination of P‐valuesYu, K; Li, Q; Bergen, AW
-
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancerHaaften, G; Dalgliesh, GL; Davies, H
-
Aberrations of EZH2 in cancerChase, A; Cross, NC
-
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B‐cell lymphomas of germinal‐center originMorin, RD; Johnson, NA; Severson, TM
-
Genetic variants in Fas signaling pathway genes and risk of gastric cancerHyland, PL; Lin, SW; Hu, N
-
Genetic variants in sex hormone metabolic pathway genes and risk of esophageal squamous cell carcinomaHyland, PL; Freedman, ND; Hu, N
-
Common genetic variants in epigenetic machinery genes and risk of upper gastrointestinal cancersSung, H; Yang, HH; Zhang, H
-
Association between genetic variants in DNA and histone methylation and telomere lengthKim, S; Parks, CG; Xu, Z
-
Tipping the lysine methylation balance in diseaseBlack, JC; Whetstine, JR
-
Alterations of global histone H3K9 and H3K27 methylation levels in bladder cancerEllinger, J; Bachmann, A; Göke, F
-
The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinomaPark, YS; Jin, MY; Kim, YJ; Yook, JH; Kim, BS; Jang, SJ
-
Decreased levels of histone H3K9me1 indicate poor prognosis in patients with renal cell carcinomaRogenhofer, S; Kahl, P; Holzapfel, S; Ruecker, A; Mueller, SC; Ellinger, J
-
Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cellsFodor, BD; Kubicek, S; Yonezawa, M
-
Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancerLi, W; Zhao, L; Zang, W
-
JMJD2B promotes epithelial‐mesenchymal transition by cooperating with β‐catenin and enhances gastric cancer metastasisZhao, L; Li, W; Zang, W
-
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastomaNorthcott, PA; Nakahara, Y; Wu, X
-
A coding single‐nucleotide polymorphism in lysine demethylase KDM4A associates with increased sensitivity to mTOR inhibitorsVan Rechem, C; Black, JC; Greninger, P
-
Influence of the KDM4A rs586339 polymorphism on overall survival in Asian non‐small‐cell lung cancer patientsMarvalim, C; Wong, JX; Sutiman, N
-
Genetic polymorphisms in the Rb‐binding zinc finger gene RIZ and the risk of lung cancerYoon, KA; Park, S; Hwangbo, B
-
Genetic variants in epigenetic genes and breast cancer riskCebrian, A; Pharoah, PD; Ahmed, S
-
Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet–gene interactions and promoter CpG island hypermethylation in colorectal cancerVogel, S; Wouters, KA; Gottschalk, RW
-
SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cellsHamamoto, R; Furukawa, Y; Morita, M
-
Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cellsKim, JM; Kim, K; Schmidt, T
-
SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinomaLiu, Y; Luo, X; Deng, J; Pan, Y; Zhang, L; Liang, H
-
SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinomaZhu, Y; Zhu, MX; Zhang, XD
-
A SMYD3 small‐molecule inhibitor impairing cancer cell growthPeserico, A; Germani, A; Sanese, P
-
Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagyShen, B; Tan, M; Mu, X
-
Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancerReynoird, N; Mazur, PK; Stellfeld, T
-
A variable number of tandem repeats polymorphism in an E2F‐1 binding element in the 5′flanking region of SMYD3 is a risk factor for human cancersTsuge, M; Hamamoto, R; Silva, FP
-
Identification of regulatory SNPs associated with genetic modifications in lung adenocarcinomaLu, TP; Hsiao, CK; Lai, LC
-
MLL3, a new human member of the TRX/MLL gene family, maps to 7q36, a chromosome region frequently deleted in myeloid leukaemiaRuault, M; Brun, ME; Ventura, M; Roizès, G; De Sario, A
-
Altered expression of MLL methyltransferase family genes in breast cancerRabello Ddo, A; Moura, CA; Andrade, RV; Motoyama, AB; Silva, FP
-
Mll3 genetic variants affect risk of gastric cancer in the Chinese Han populationLi, B; Liu, HY; Guo, SH; Sun, P; Gong, FM; Jia, BQ
-
Interaction between MLL3 genetic polymorphisms, smoking, and alcohol drinking in laryngeal cancer: a case–control studyChen, D; Gong, L; Jiang, Q; Wang, X; Zhang, B
-
Frequent alteration of MLL3 frameshift mutations in microsatellite deficient colorectal cancerWatanabe, Y; Castoro, RJ; Kim, HS
-
Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinomaBalakrishnan, A; Bleeker, FE; Lamba, S
-
Somatic cancer mutations in the MLL3‐SET domain alter the catalytic properties of the enzymeWeirich, S; Kudithipudi, S; Kycia, I; Jeltsch, A
-
Association of MLL3 expression with prognosis in gastric cancerLi, B; Liu, HY; Guo, SH; Sun, P; Gong, FM; Jia, BQ
-
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemiaChen, C; Liu, Y; Rappaport, AR
-
Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humansDoyon, Y; Selleck, W; Lane, WS; Tan, S; Cote, J
-
KAT5 and KAT6B are in positive regulation on cell proliferation of prostate cancer through PI3K‐AKT signalingHe, W; Zhang, MG; Wang, X
-
Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancerLaurberg, JR; Brems‐Eskildsen, AS; Nordentoft, I
-
Role of Tip60 in human melanoma cell migration, metastasis, and patient survivalChen, G; Cheng, Y; Tang, Y; Martinka, M; Li, G
-
TIP60 as a potential marker for the malignancy of gastric cancerSakuraba, K; Yokomizo, K; Shirahata, A
-
Down‐regulation of Tip60 gene as a potential marker for the malignancy of colorectal cancerSakuraba, K; Yasuda, T; Sakata, M
-
Targeted re‐sequencing identified rs3106189 at the 5′ UTR of TAPBP and rs1052918 at the 3′ UTR of TCF3 to be associated with the overall survival of colorectal cancer patientsShao, J; Lou, X; Wang, J
-
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross‐contamination resulting in cell line redundancy and misidentificationSchweppe, RE; Klopper, JP; Korch, C
-
The MYST family of histone acetyltransferases and their intimate links to cancerAvvakumov, N; Côté, J
-
Status of epigenetic chromatin modification enzymes and esophageal squamous cell carcinoma risk in northeast Indian populationSingh, V; Singh, LC; Singh, AP
-
Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancerYu, L; Liang, Y; Cao, X
-
The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB‐binding proteinBorrow, J; Stanton, VP; Andresen, JM
-
Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocationKitabayashi, I; Aikawa, Y; Yokoyama, A
-
Comprehensive profiling of 8p11‐12 amplification in breast cancerGelsi‐Boyer, V; Orsetti, B; Cervera, N
-
KAT6A, a chromatin modifier from the 8p11‐p12 amplicon is a candidate oncogene in luminal breast cancerTurner‐Ivey, B; Guest, ST; Irish, JC
-
Tumor evolution and intratumor heterogeneity of an oropharyngeal squamous cell carcinoma revealed by whole‐genome sequencingZhang, XC; Xu, C; Mitchell, RM
-
Altered DNA methylation profile in Norwegian patients with autoimmune Addison's diseaseBjanesoy, TE; Andreassen, BK; Bratland, E
-
Class IIa histone deacetylases: regulating the regulatorsMartin, M; Kettmann, R; Dequiedt, F
-
Down‐regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrestFan, J; Lou, B; Chen, W
-
The many roles of histone deacetylases in development and physiology: implications for disease and therapyHaberland, M; Montgomery, RL; Olson, EN
-
HDAC5 promotes colorectal cancer cell proliferation by up‐regulating DLL4 expressionHe, P; Liang, J; Shao, T; Guo, Y; Hou, Y; Li, Y
-
No association between polymorphisms in the histone deacetylase genes and the risk of lung cancerPark, JM; Lee, GY; Choi, JE
-
Differential expression of selected histone modifier genes in human solid cancersOzdağ, H; Teschendorff, AE; Ahmed, AA
-
Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenibLachenmayer, A; Toffanin, S; Cabellos, L
-
SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformationBarber, M; Michishita‐Kioi, E; Xi, Y
-
High expression of Sirt7 served as a predictor of adverse outcome in breast cancerGeng, Q; Peng, H; Chen, F; Luo, R; Li, R
-
Hsa‐miR‐125b suppresses bladder cancer development by down‐regulating oncogene SIRT7 and oncogenic long non‐coding RNA MALAT1Han, Y; Liu, Y; Zhang, H
-
MicroRNA‐3666‐induced suppression of SIRT7 inhibits the growth of non‐small cell lung cancer cellsShi, H; Ji, Y; Zhang, D; Liu, Y; Fang, P
-
SIRT7 exhibits oncogenic potential in human ovarian cancer cellsWang, HL; Lu, RQ; Xie, SH
-
Association between SIRT1 gene polymorphisms and breast cancer in EgyptiansRizk, SM; Shahin, NN; Shaker, OG
-
Association of SIRT1 gene variation with visceral obesityPeeters, AV; Beckers, S; Verrijken, A
-
SIRT1 genetic variation and mortality in type 2 diabetes: interaction with smoking and dietary niacinZillikens, MC; Meurs, JB; Sijbrands, EJ
-
SIRT1 gene, age‐related diseases, and mortality: the Leiden 85‐plus studyKuningas, M; Putters, M; Westendorp, RG; Slagboom, PE; Heemst, D
@Phil_Robichaud
@deepthiw
@JoseServera